Abstract: A disc driving apparatus has two bases. Both bases swing about their parallel shafts provided at the same side of the bases between positions where the bases chuck a disc-shaped recording medium and positions where they release the medium. A member for rotating the medium is provided for one of the bases, and another member for connecting the medium and the member in order to rotate them together is provided for the other of the bases. The disc driving apparatus also has a pickup for accessing the medium, a chucking mechanism for chucking the medium, a pickup moving mechanism, and a locking mechanism. The pickup can be moved in the radial direction of the medium. The pickup moving mechanism moves the pickup in the radial direction of the medium when the chucking mechanism releases the medium. The locking mechanism locks the movement of the pickup after it is moved to a specified position by the pickup moving mechanism.

Abstract: The present invention provides novel thiazolidine-2,4-dione derivatives possessing blood sugar-lowering action and aldose reductase-inhibitory action, their salts, their preparative processes and drugs containing them, and relates to thiazolidine-2,4-dione derivatives represented by a general formula (1) ##STR1## [wherein R.sup.1 and R.sup.2 denote identically or differently hydrogen atoms or lower alkyl groups, R.sup.3 denotes a phenyl group, naphthyl group, benzoyl group or 5-membered or 6-membered heteroring and its benzene-condensed ring, which may have one or more substituents, A denotes a carbonyl group, sulfonyl group or bonding hand, and B denotes a lower alkylene, lower alkenylene or bonding hand], or their salts, or thiazolidine-2,4-dione derivatives represented by a general formula (2) ##STR2## [wherein R.sup.4 denotes a hydrogen atom or lower alkyl group, and R.sup.1 and R.sup.3 are same as above ], or their salts.

Abstract: The present invention provides novel thiazolidine-2,4-dione derivatives possessing blood sugar-lowering action and aldose reductase-inhibitory action, their salts, their preparation processes and drugs containing them, and relates to thiazolidine-2,4-dione derivatives represented by a general formula (1) ##STR1## [wherein R.sup.1 and R.sup.2 denote identically or differently hydrogen atoms, halogens, lower alkyl groups, hydroxyl groups, lower alkoxy groups, nitro groups or amino groups (said amino group may be substituted with lower alkyl group or lower alkanoyl group, R.sup.3 denotes a hydrogen atom or lower alkyl group, A denotes a lower alkylene or carbonyl group, and B and W denote differently lower alkylenes, carbonyl groups or bonding hands], or their salts.

Abstract: Phenoxyalkylcarboxylic acid derivatives represented by the following formula (I) ##STR1## having a strong and selective leukotriene antagonistic action and useful for prophylaxis and therapy of allergic diseases as asthma and processes of preparing the same.

Abstract: Phenoxyalkylcarboxylic acid derivatives of the following formula, ##STR1## wherein R.sup.1 indicates a hydrogen atom, a methyl group or an ethyl group, m is equal to 2, 3 or 4, and n is equal to 3 or 4, their alkali salts and hydrates thereof are useful as antiallergic agents.

Abstract: A function inspection system having a plurality of inspection units for inspecting the operation of an electronic appliance. The system includes a system of traversers which convey the electronic appliance to different inspection units. The inspection units inspect different functions of the electronic appliance. The traversers are controlled by a controller. The electronic appliance is a printed circuit board in the preferred embodiments.

Abstract: An ameliorating agent for dysmnesia, comprising as an effective component or components at least one of pyrazolo[1,5-a]pyridine derivatives represented by the general formula: ##STR1## wherein R.sup.1 and R.sup.2 are independently hydrogen or a lower alkyl of 1-4 carbons, R.sup.3 is hydrogen or a lower alkyl of 1-3 carbons or a lower alkoxy of 1-3 carbons.

Abstract: Phenoxyalkylcarboxylic acid derivatives of the following formula, ##STR1## wherein R.sup.1 indicates hydrogen atom, methyl group or ethyl group, m is an integer from 2 to 5, and n is an integer from 3 to 8, X.sup.1 and X.sup.2 each independently represent sulfur atom, oxygen atom, sulfinyl group or sulfonyl group, proviso X.sup.1 and X.sup.2 are not simultaneously oxygen atom; their alkali salts and hydrates thereof are useful as antiallergic agents.

Abstract: A signal synchronizing system comprising first circuit having a plurality of sync signals, second circuit having a plurality of sync signals corresponding to the sync signals of the first circuit, respectively, and a synchronizing control circuit which synchronizes output signals of the second circuit with output signals of the first circuit. The synchronizing control circuit inputs the plurality of sync signals of each of the first and second circuits, and outputs a control signal to the second circuit.

Abstract: Benzimidazole derivatives of the following formula, ##STR1## wherein R.sup.1 indicates hydrogen atom, lower alkyl group having carbon atoms of 1 to 6 or dimethylaminopropyl group, R.sup.2 indicates hydrogen atom or lower alkanoyl group having carbon atoms of 1 to 3, R.sup.3 indicates hydrogen atom, lower alkyl group having carbon atoms of 1 to 3 or lower alkanoyl group having carbon atoms of 1 to 3, X indicates sulfur atom, sulfinyl group, sulfonyl group, amino group or methylene group, A indicates alkylene group having carbon atoms of 1 to 12, which alkylene group may optionally be substituted by hydroxy group or lower alkyl group having carbon atoms of 1 to 3, --(CHR')N--CR".dbd.CR"--(CHR')M--, ##STR2## (in which R' and R" are each independently hydrogen atom, lower alkyl group having carbon atoms of 1 to 3 or hydroxy group, and n and m are equal to 0, 1, 2 or 3) and Y indicates oxygen atom or sulfur atom; their acid or alkali salts and hydrate thereof are useful as antiallergic agents.